Mizuho Markets Cayman LP Has $140,000 Stake in Centene Corporation $CNC

Mizuho Markets Cayman LP lowered its position in shares of Centene Corporation (NYSE:CNC) by 87.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,932 shares of the company’s stock after selling 26,818 shares during the period. Mizuho Markets Cayman LP’s holdings in Centene were worth $140,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CNC. Addison Advisors LLC lifted its holdings in shares of Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after buying an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Centene in the third quarter valued at about $27,000. WPG Advisers LLC increased its position in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares during the period. Bogart Wealth LLC raised its stake in Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after purchasing an additional 991 shares in the last quarter. Finally, Ameriflex Group Inc. boosted its holdings in Centene by 152.5% in the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after purchasing an additional 610 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Centene Stock Performance

NYSE CNC opened at $34.77 on Tuesday. The firm’s 50 day simple moving average is $42.61 and its 200 day simple moving average is $38.51. The firm has a market capitalization of $17.10 billion, a price-to-earnings ratio of -2.55, a P/E/G ratio of 0.76 and a beta of 0.48. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.03.

Centene (NYSE:CNC) last announced its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company’s revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts expect that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CNC. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $41.00 target price on shares of Centene in a report on Monday, February 9th. Argus raised Centene to a “hold” rating in a research report on Monday, February 9th. Wells Fargo & Company set a $44.00 price objective on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Mizuho set a $41.00 target price on Centene and gave the company a “neutral” rating in a research report on Tuesday, March 10th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Centene presently has an average rating of “Hold” and a consensus target price of $42.06.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.